LONDON –
The body responsible for public research funding in the UK has set out a quantified defence of its multi-year support for quantum science, detailing targeted training awards, early‑career fellowships and a multi‑hundred‑million‑pound investment plan it says will underpin commercial scale-up and jobs growth in the sector.
The statement, issued by Prof Charlotte Deane of UK Research and Innovation, responds directly to recent criticism about the sufficiency of UK funding for fundamental science and talent retention. It supplies exact programme milestones and near‑term financial commitments intended to anchor industry and academic activity through commercialisation phases that market participants regard as capital‑intensive and timing‑sensitive. UKRI, a non‑departmental public body sponsored by the Department for Science, Innovation and Technology, allocates public research and innovation funding across nine councils and Innovate UK under a framework agreed with government but operates at arm’s length on individual funding decisions.
Investment milestones and talent pipeline
Prof Deane cites a decade of council-level funding focused on physics and quantum research and lists discrete outputs and commitments that together describe a deliberate pipeline-building approach aligned with the UK’s National Quantum Strategy:
- Support for “100 PhDs in quantum technology launched in 2024”, intended to deepen the specialist skills base available to universities and spin‑outs.
- Provision of “quantum computing industrial doctorate awards” to embed doctoral researchers within corporate R&D and supply chains.
- Funding “14 early-career fellows in the last 18 months” to stabilise emerging research leaders and their teams.
- Planning “over £1bn of investment in the coming four years” across quantum‑relevant programmes and infrastructure.
She also notes the sector showcased “is making a difference now, with the scope to create 100,000 jobs in the next 20 years.” Those figures are presented as outcomes and projections tied to public funding and accompanying procurement signals, rather than as standalone forecasts.
Commercial anchor through procurement
Public procurement is positioned in the statement as a complementary tool to research grants, reflecting wider UK policy that uses government purchasing power to de‑risk early markets. Prof Deane references a government procurement scheme described as a “further £1bn procurement programme” intended to create demand for UK‑based quantum systems and services. The programme is framed as sitting alongside UKRI’s grant‑based support: while UKRI underwrites research and training, procurement budgets controlled by ministers are used to act as first customer for emerging platforms.
The combination of research funding and procurement commitments is framed as a mechanism to reduce early‑market revenue risk for companies and to provide reference‑class customers at scale, particularly in areas such as secure communications, high‑performance computing and advanced sensing where government itself is a major buyer.
How the funding maps to sector needs
The numerical commitments target two core gaps that typically slow nascent deep‑tech sectors: human capital and first‑customer demand. The cited PhD and industrial doctorate awards address specialist labour supply that firms and university spin‑outs require to mature prototype systems; the early‑career fellowships aim to stabilise research groups that underpin long‑term platform development and IP generation.
Meanwhile, the planned public procurement funding is described as a pathway to bridge demonstration projects and initial commercial deployments. In policy terms, the package is designed to keep UK‑based firms and laboratories from relocating at the point where private capital becomes most sensitive to timescales and technical risk.
This package, as outlined, connects discrete policy instruments – doctoral training, industrial doctorates, fellowships and procurement – into a single sequencing strategy intended to move science out of laboratories and into funded customer projects, while keeping early‑stage ownership and know‑how in the UK.
“These record levels of investment make the UK one of the most exciting and well-supported places in the world for quantum computing researchers, companies and students.”
– Prof Charlotte Deane, UK Research and Innovation
Implications for industry structure and market entrants
For companies, the effect of sustained public backing is twofold. First, a reliable pipeline of doctoral and postdoctoral researchers reduces one of the primary bottlenecks for scaling hardware and software development teams. Second, visible procurement programmes can alter investor and supplier calculus by offering a clearer route to initial revenues and long‑term contracts, which in turn can influence where global firms locate design centres and where start‑ups choose to incorporate.
Firms seeking to commercialise quantum technologies typically face extended development timelines and capital intensity across specialised supply chains (cryogenics, control electronics, custom semiconductors and software stacks). The funding elements cited in the statement tackle upstream risk (skills, foundational science) and downstream demand risk (procurement), which together inform corporate decisions on R&D location, hiring and partner selection, as well as shaping which parts of the value chain are most likely to cluster in the UK.
Governance and accountability
The statement attributes the outcomes to council‑level investments over the “last 10 years” and frames the current commitments as part of an ongoing public funding cycle, governed under UKRI’s framework agreement with the Department for Science, Innovation and Technology, which sets out roles, accountability and performance expectations for the public body. That framework, underpinned by the Higher Education and Research Act and periodic spending reviews, is intended to balance ministerial priorities with UKRI’s operational independence in individual funding decisions.
Where public bodies combine grant funding with procurement, governance processes and procurement rules will define eligibility, evaluation criteria and intellectual property arrangements that determine how value is shared between universities, spin‑outs and suppliers. Formal oversight mechanisms – including audit requirements, impact reporting and parliamentary scrutiny – will also shape how far the quantum package is judged to deliver on promised jobs and growth.
Specific procedural details for the procurement activity are not laid out in the statement; the referenced “further £1bn procurement programme” indicates a funding envelope and policy intent but does not replace the formal procurement timetable and tender documentation that will govern supplier participation.
Near‑term status and next procedural steps
The funding statement confirms current and planned budgetary commitments and enumerates recent academic‑training outputs. It affirms that UKRI is planning “over £1bn of investment in the coming four years” and that the government has signalled “a further £1bn procurement programme” to support market development.
In the near term, attention will shift to how these headline figures are translated into specific calls, competitions and contract notices, and to whether the next UK spending review sustains the trajectory implied by the statement. For industry, the practical test will be the speed and clarity with which those processes are launched – and whether they are predictable enough to support multi‑year hiring and investment decisions in one of the UK’s most strategically sensitive technology sectors.
